Pfiz­er plans $465M man­u­fac­tur­ing fa­cil­i­ty at Michi­gan base; Chi­na's Ts­inghua Uni­ver­si­ty inks dis­cov­ery deal with Bris­tol-My­ers

→ Re­cent­ly bat­tling some trou­bling short­ages in ster­ile in­jecta­bles, Pfiz­er $PFE an­nounced it’s step­ping up its man­u­fac­tur­ing game by spend­ing $465 mil­lion on a new fa­cil­i­ty on its Portage, MI site. Com­mand­ing 400,000 square feet, con­struc­tion of the new fa­cil­i­ty is planned for next spring and sched­uled to wrap up in 2021, with goals to be­gin pro­duc­tion by 2024. The ex­pan­sion will add 450 staffers to the 2,200 Pfiz­er al­ready em­ploys at its Portage plant un­der the unit name Mod­u­lar Asep­tic Pro­cess­ing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.